India, Oct. 14 -- Two new lab studies displayed potential for the holistic carob-based ingredient Csat, developed by nutraceutical leaders Pharmactive Biotech Products, S.L.U., to exert a positive impact on the gut microbiome, helping to stimulate GLP-1 and support satiety.

The first study, an in vitro study published in February 2026 in the journal Bioscience, compared Csat with a control medium and two individual carob fractions, a galactomannan-rich seed fraction and a pulp extract. Assessment of the microbial composition 24 and 48 hours later revealed that Csat exerted the strongest effect on microbial activity, producing the highest amounts of short-chain fatty acids (SCFA) acetate, propionate, and butyrate.

Csat is a standardized...